Literature DB >> 18844790

Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A.

Eppie M Yiu1, Joshua Burns, Monique M Ryan, Robert A Ouvrier.   

Abstract

Although Charcot-Marie-Tooth disease type 1A (CMT1A) initially manifests in the first decade, there are no large studies describing its neurophysiologic features in childhood. We report neurophysiologic findings in 80 children aged 2-16 years with CMT1A who underwent median motor and sensory nerve conduction studies. Neurophysiologic abnormalities were present in all children. Median motor nerve conduction velocity was invariably less than 33 m/s (mean 18.7 m/s, range 9.0-32.9 m/s), with conduction velocities significantly slower in children aged 7-16 years compared with children aged 6 years and below. All children had prolonged distal motor latencies (mean 7.3 ms, range 4.0-12.3 ms). The compound muscle action potential (CMAP) amplitude was reduced from an early age (mean 7.1 mV, range 2.1-13.5 mV), and its normal increase with age was attenuated. Median sensory responses were present in only seven children, all aged less than 9 years and with slowed sensory conduction. Neurophysiologic abnormalities are present in all children with CMT1A from the age of 2 years. Motor conduction slowing progresses through the first 6 years of life and thereafter remains stable. CMAP amplitude is reduced from an early age, and the normal physiologic increase with age is attenuated. Median sensory responses may be recorded in younger children, and their presence does not exclude the diagnosis of CMT1A.

Entities:  

Mesh:

Year:  2008        PMID: 18844790     DOI: 10.1111/j.1529-8027.2008.00182.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  20 in total

1.  Soluble neuregulin-1 modulates disease pathogenesis in rodent models of Charcot-Marie-Tooth disease 1A.

Authors:  Robert Fledrich; Ruth M Stassart; Axel Klink; Lennart M Rasch; Thomas Prukop; Lauren Haag; Dirk Czesnik; Theresa Kungl; Tamer A M Abdelaal; Naureen Keric; Christine Stadelmann; Wolfgang Brück; Klaus-Armin Nave; Michael W Sereda
Journal:  Nat Med       Date:  2014-08-24       Impact factor: 53.440

2.  Bands of Fontana are caused exclusively by the sinusoidal path of axons in peripheral nerves and predict axon path; evidence from rodent nerves and physical models.

Authors:  Luke M Alvey; James F X Jones; Cathal Tobin-O'Brien; Mark Pickering
Journal:  J Anat       Date:  2018-11-13       Impact factor: 2.610

3.  Clinical progression in Charcot-Marie-Tooth disease type 1A duplication: clinico-electrophysiological and MRI longitudinal study of a family.

Authors:  José Berciano; Elena Gallardo; Antonio García; César Ramón; Jon Infante; Onofre Combarros
Journal:  J Neurol       Date:  2010-05-05       Impact factor: 4.849

4.  Nerve conduction velocity in CMT1A: what else can we tell?

Authors:  F Manganelli; C Pisciotta; M M Reilly; S Tozza; A Schenone; G M Fabrizi; T Cavallaro; G Vita; L Padua; F Gemignani; M Laurà; R A C Hughes; A Solari; D Pareyson; L Santoro
Journal:  Eur J Neurol       Date:  2016-07-14       Impact factor: 6.089

5.  Charcot-Marie-Tooth Disease Type 1A: Influence of Body Mass Index on Nerve Conduction Studies and on the Charcot-Marie-Tooth Examination Score.

Authors:  Nivedita U Jerath; Michael E Shy
Journal:  J Clin Neurophysiol       Date:  2017-11       Impact factor: 2.177

6.  Determinants of reduced health-related quality of life in pediatric inherited neuropathies.

Authors:  J Burns; S Ramchandren; M M Ryan; M Shy; R A Ouvrier
Journal:  Neurology       Date:  2010-08-24       Impact factor: 9.910

7.  A new locus for X-linked dominant Charcot-Marie-Tooth disease (CMTX6) is caused by mutations in the pyruvate dehydrogenase kinase isoenzyme 3 (PDK3) gene.

Authors:  Marina L Kennerson; Eppie M Yiu; David T Chuang; Aditi Kidambi; Shih-Chia Tso; Carolyn Ly; Rabia Chaudhry; Alexander P Drew; Gary Rance; Martin B Delatycki; Stephan Züchner; Monique M Ryan; Garth A Nicholson
Journal:  Hum Mol Genet       Date:  2013-01-07       Impact factor: 6.150

8.  Development and validation of the Charcot-Marie-Tooth Disease Infant Scale.

Authors:  Melissa R Mandarakas; Manoj P Menezes; Kristy J Rose; Rosemary Shy; Kate Eichinger; Maria Foscan; Timothy Estilow; Rachel Kennedy; Karen Herbert; Paula Bray; Kathryn Refshauge; Monique M Ryan; Eppie M Yiu; Michelle Farrar; Hugo Sampaio; Isabella Moroni; Emanuela Pagliano; Davide Pareyson; Sabrina W Yum; David N Herrmann; Gyula Acsadi; Michael E Shy; Joshua Burns; Oranee Sanmaneechai
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

9.  Shortened internodal length of dermal myelinated nerve fibres in Charcot-Marie-Tooth disease type 1A.

Authors:  Mario A Saporta; Istvan Katona; Richard A Lewis; Stacey Masse; Michael E Shy; Jun Li
Journal:  Brain       Date:  2009-12       Impact factor: 13.501

Review 10.  New evidence for secondary axonal degeneration in demyelinating neuropathies.

Authors:  Kathryn R Moss; Taylor S Bopp; Anna E Johnson; Ahmet Höke
Journal:  Neurosci Lett       Date:  2020-12-24       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.